Salarius Pharmaceuticals Stock Market Value
| SLRX Stock | USD 1.52 0.15 10.95% |
| Symbol | Salarius |
Salarius Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Salarius Pharmaceuticals. If investors know Salarius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Salarius Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.14) | Quarterly Revenue Growth (1.00) | Return On Assets (0.54) | Return On Equity (1.20) |
The market value of Salarius Pharmaceuticals is measured differently than its book value, which is the value of Salarius that is recorded on the company's balance sheet. Investors also form their own opinion of Salarius Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Salarius Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Salarius Pharmaceuticals' market value can be influenced by many factors that don't directly affect Salarius Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Salarius Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Salarius Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Salarius Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Salarius Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Salarius Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Salarius Pharmaceuticals.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Salarius Pharmaceuticals on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Salarius Pharmaceuticals or generate 0.0% return on investment in Salarius Pharmaceuticals over 30 days. Salarius Pharmaceuticals is related to or competes with Akari Therapeutics, Nutriband, Aileron Therapeutics, SAB Biotherapeutics, Vaccinex, GeoVax Labs, and Corvus Pharmaceuticals. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer tr... More
Salarius Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Salarius Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Salarius Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 27.43 | |||
| Value At Risk | (9.15) | |||
| Potential Upside | 9.59 |
Salarius Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Salarius Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Salarius Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Salarius Pharmaceuticals historical prices to predict the future Salarius Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.14) |
Salarius Pharmaceuticals Backtested Returns
Salarius Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0084, which indicates the firm had a -0.0084% return per unit of risk over the last 3 months. Salarius Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Salarius Pharmaceuticals' Risk Adjusted Performance of (0.01), coefficient of variation of (3,601), and Variance of 31.14 to confirm the risk estimate we provide. The entity has a beta of 1.17, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Salarius Pharmaceuticals will likely underperform. At this point, Salarius Pharmaceuticals has a negative expected return of -0.0467%. Please make sure to validate Salarius Pharmaceuticals' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Salarius Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.17 |
Insignificant reverse predictability
Salarius Pharmaceuticals has insignificant reverse predictability. Overlapping area represents the amount of predictability between Salarius Pharmaceuticals time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Salarius Pharmaceuticals price movement. The serial correlation of -0.17 indicates that over 17.0% of current Salarius Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Salarius Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Salarius Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Salarius Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Salarius Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Salarius Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Salarius Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Salarius Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Salarius Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Salarius Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Salarius Pharmaceuticals Lagged Returns
When evaluating Salarius Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Salarius Pharmaceuticals stock have on its future price. Salarius Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Salarius Pharmaceuticals autocorrelation shows the relationship between Salarius Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Salarius Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Salarius Stock Analysis
When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.